R8-RGD-lipo

General Information


DRACP ID  DRACP05614

Peptide Name   R8-RGD-lipo

Sequence  RRRRRRRRRGDfK

Sequence Length  13

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides Membrane-targeted Cell-penetrating peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Arg9<--->Lys13

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  Cysteine modified octa-arginine conjugated to the branch of lysine

Chiral  Mix



Physicochemical Information


Formula  C66H128N40O14

Absent amino acids  ACEFHILMNPQSTVWY

Common amino acids  R

Mass  192019

Pl  13.05

Basic residues  10

Acidic residues  1

Hydrophobic residues  0

Net charge  9

Boman Index  -14761

Hydrophobicity  -371.54

Aliphatic Index  0

Half Life 
  /

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 24651033

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




Cppsite ID  2498

DRACP is developed by Dr.Zheng's team.